中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | dl-threo-phenylserine | —— | C9H11NO3 | 181.191 |
—— | β-hydroxyphenylalanine | 50897-27-3 | C9H11NO3 | 181.191 |
—— | methyl erythro-(+/-)-β-hydroxyphenylalaninate | 38114-29-3 | C10H13NO3 | 195.218 |
—— | (2RS,3RS)-2-amino-3-hydroxy-3-phenyl-propionic acid ethyl ester | —— | C11H15NO3 | 209.245 |
—— | (1RS,2SR)-2-amino-1-phenyl-propane-1,3-diol | —— | C9H13NO2 | 167.208 |
—— | N-acetyl-β-hydroxy-D,L-phenylalanine | 91199-27-8 | C11H13NO4 | 223.229 |
—— | (2S,3S)-erythro-N-acetyl-β-phenylserine | 46506-67-6 | C11H13NO4 | 223.229 |
—— | methyl (2S,3S)-2-azido-3-hydroxy-3-phenylpropionate | 133179-94-9 | C10H11N3O3 | 221.216 |
—— | (2RS,3RS)-2-(2,2-dichloro-acetylamino)-3-hydroxy-3-phenyl-propionic acid | —— | C11H11Cl2NO4 | 292.119 |
—— | (2RS,3RS)-2-benzoylamino-3-hydroxy-3-phenyl-propionic acid | 92963-95-6 | C16H15NO4 | 285.299 |
—— | N-acetyl-erythro-DL-β-phenylserine ethyl ester | —— | C13H17NO4 | 251.282 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (2R,3R)-β-phenylserine | 7352-06-9 | C9H11NO3 | 181.191 |
—— | methyl erythro-(+/-)-β-hydroxyphenylalaninate | 38114-29-3 | C10H13NO3 | 195.218 |
—— | (2RS,3RS)-2-amino-3-hydroxy-3-phenyl-propionic acid ethyl ester | —— | C11H15NO3 | 209.245 |
—— | (1RS,2SR)-2-amino-1-phenyl-propane-1,3-diol | —— | C9H13NO2 | 167.208 |
—— | (2R,3R)-erythro-N-acetyl-β-phenylserine | 669777-50-8 | C11H13NO4 | 223.229 |
—— | (2S,3S)-2-(2,2-dichloro-acetylamino)-3-hydroxy-3-phenyl-propionic acid | 906366-62-9 | C11H11Cl2NO4 | 292.119 |
—— | (2RS,3RS)-2-(2,2-dichloro-acetylamino)-3-hydroxy-3-phenyl-propionic acid | —— | C11H11Cl2NO4 | 292.119 |
—— | (αRS,βRS)-N-[(benzyloxy)carbonyl]-β-hydroxy-phenylalanine | 5817-49-2 | C17H17NO5 | 315.326 |
—— | methyl (2S,3S)-2-(tert-butoxycarbonyl)amino-3-hydroxy-3-phenylpropionate | 17193-36-1 | C15H21NO5 | 295.335 |
Supramolecular plasmonic magnetogels comprising two different nanoparticle architectures were developed and evaluated as potential nanocarriers for multimodal cancer therapy with reversible photothermia capabilities and tuneable drug release.